Vivimed Labs Limited has informed the Exchange about Corporate Insolvency Resolution Process
VIVIMEDLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.4 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The National Company Law Tribunal (NCLT), Bengaluru Bench has admitted Vivimed Labs Limited into the Corporate Insolvency Resolution Process under the Insolvency and Bankruptcy Code, 2016. The insolvency commencement date is 15.04.2026. The company has appointed T Narayana Swamy as the Interim Resolution Professional. Creditors have been called upon to submit their claims with proof by 01.05.2026. The estimated closure date for the resolution process is 11.10.2026. The company was originally incorporated on 22.09.1988 and is registered in Karnataka.
This is an extremely negative development for shareholders as the company is now under formal insolvency proceedings. Existing equity shareholders will likely face severe dilution or complete loss of value if a resolution plan results in debt-for-equity swap or if the company is liquidated. Trading in the stock may be suspended or face significant price collapse.